Post-Translational Modifications to Improve Therapeutic Half-Life of Protein-Based Therapeutics
Tuesday, 10 September 2024, 00:56
Enhancing Longevity Through Post-Translational Modifications
Post-translational modifications (PTMs) play a significant role in the search for improved therapeutic half-life of protein-based therapeutics. These alterations affect protein stability and function, which are critical for their efficacy in biotherapeutics.
The Role of Post-Translational Modifications
- PTMs can significantly impact protein aggregation.
- These modifications can also influence how proteins are received in biological systems.
Implications for Protein-Based Treatments
Understanding the effects of post-translational modifications enables researchers to create more effective biotherapeutic proteins, maximizing patient outcomes.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.